FEMSelect Ltd 2022-02-09 Health serious FDA
Health · FDA · Recall #FDA-Z-0556-2022
The EnPlace is a single use trans-vaginal pelvic floor repair system which enables… Recall
Issued February 9, 2022 · FEMSelect Ltd
In February 2022, FEMSelect Ltd recalled the The EnPlace is a single use trans-vaginal pelvic floor repair system which enables…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Certain lots may not have been packaged wth the Channel Tube Limiter.
What you should do
- 1 Stop using The EnPlace is a single use trans-vaginal pelvic floor repair system which enables… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact FEMSelect Ltd to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- FEMSelect Ltd
- Category
- Health
- Recall date
- February 9, 2022
- Units affected
- Not reported
- Sold at
- US Nationwide distribution in the state of Georgia.
- Recall number
- FDA-Z-0556-2022
- Made in
- Israel
- Issuing agency
- FDA
In context
- FEMSelect Ltd has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.